Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulin.

Respiratory syncytial virus (RSV) causes serious illness (lower respiratory illness) in preterm infants. RSV antibody-enriched immunoglobulin (RSVIG) that was lyophilized (LYO) protected against RSV lower respiratory illness. The Food and Drug Administration now requires an additional viral inactiva...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Groothuis, J R, Simoes, E A, Lehr, M V, Kramer, A A, Hemming, V G, Rodriguez, W J, Arrobio, J, Welliver, R C, Siber, G R
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162602/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7793870/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.39.3.668
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!